SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010967
Filing Date
2021-08-09
Accepted
2021-08-09 16:07:58
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20210630x10q.htm   iXBRL 10-Q 2161121
2 EX-3.1 ocul-20210630xex3d1.htm EX-3.1 62331
3 EX-31.1 ocul-20210630xex31d1.htm EX-31.1 12009
4 EX-31.2 ocul-20210630xex31d2.htm EX-31.2 8449
5 EX-32.1 ocul-20210630xex32d1.htm EX-32.1 4991
6 EX-32.2 ocul-20210630xex32d2.htm EX-32.2 4972
  Complete submission text file 0001558370-21-010967.txt   6793043

Data Files

Seq Description Document Type Size
7 EX-101.SCH ocul-20210630.xsd EX-101.SCH 48231
8 EX-101.CAL ocul-20210630_cal.xml EX-101.CAL 49364
9 EX-101.DEF ocul-20210630_def.xml EX-101.DEF 139547
10 EX-101.LAB ocul-20210630_lab.xml EX-101.LAB 348182
11 EX-101.PRE ocul-20210630_pre.xml EX-101.PRE 296134
12 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20210630x10q_htm.xml XML 1004412
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 211156508
SIC: 2834 Pharmaceutical Preparations